Sympathetic denervation of the renal arteries: A new therapeutic strategy in the management of refractory arterial hypertension;Denervación simpática de arterias renales: Una nueva estrategia terapéutica en el manejo de la hipertensión arterial refractaria

Nefrologia

Volumn 32, Issue 5, 2012, Pages 555-557

  Aranda Lara, Pedro ^a   Martínez Esteban, M Dolores ^a   Muñoz, José J ^a   Hernández Marrero, Domingo ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; HYPERTENSION; INNERVATION; KIDNEY; SYMPATHECTOMY;

HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 84868221365     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Jul.11572     Document Type: Editorial

References (19)

1. Banegas JR, Jovell A, Abarca B, Aguilar M, Aguilera L, Aranda P, et al. Hipertensión arterial y política de salud en España. Med Clin (Barc) 2009;132(6):222-9.
2. Laves CM, Vander Hoorn H, Rodgers A. Global burden of blood pressure-related disease, 2001. Lancet 2008;371:1513-8.
3. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RA. Resistant hypertension: diagnosis, evaluation and treatment: a scientific statement from the American Heart Association Professional Education Committee for the Council for High Blood Pressure Research. Circulation 2008;117:e510-e526.
4. Erdine S, Arslan E, Coca A. Resistant Hypertension. European Society Hypertension. Scientific Newsleter. Updated on Hypertension management 2011;12 (no 15):27-8.
5. Alderman MH, Budner N, Cohen H, Lamport B, Ooi WL. Prevalence of drugs resistant hypertension. Hypertension 1988;11 suppl II:71-5.
6. Schaid MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009;54:1195-201.
7. Mohaupt MG, Schmidli J, Luft FC. Management of uncontrolled hypertension with a carotid sinus stimulation device. Hypertension 2007;50:825-8.
8. Schmieder RE, Redon J, Grassi G, Kjeldsen S, Mancia G, Narkiewicz K, et al. ESH Position Paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens 2012;30(5):837-41.
9. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009;54:690-7.
10. Tsioufis C, Kordalis A, Lessas D, Anastosopoulos I, Tsiachiris D, Papademetriou V, et al. Pathophysiology of resistant hypertension: the role of sympathetiv nervous system. Int J Hypertens 2011;64:214-26.
11. Di Bona GF, Kopp VC. Neural control of renal function. Physiol Rev 1997;77:175-97.
12. Pietzsch JB, Geisler B, Esler M. Efficacy and Clinical and Economic effectiviness in resistant hypertensive subgroups. J Am Coll Cardiol 2012;59:E1716.
13. Krum H, Schlaid M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof-ofprinciple cohort study. Lancet 2009;373:1275-81.
14. Simplicity HTN-1 Investigators 2011. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-7.
15. Simplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RF, et al. Renal sympathetic denervation in patients with treatment resistant hypertension (The Simplicity THN-2 trial): a randomised control trial. Lancet 2010;376:1903-9.
16. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000;36:538-542.
17. Narkiewick K, van de Borne PJH, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998;98:772-6.
18. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002;106:1974-9.
19. De la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, et al. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 2012;30:1211-6.